1 | | - | Sixty-ninth Legislative Assembly of North Dakota |
---|
2 | | - | In Regular Session Commencing Tuesday, January 7, 2025 |
---|
3 | | - | SENATE BILL NO. 2280 |
---|
4 | | - | (Senators Meyer, Barta, Bekkedahl, Cleary) |
---|
5 | | - | (Representatives Nelson, Warrey) |
---|
6 | | - | AN ACT to create and enact chapter 26.1-36.12 of the North Dakota Century Code, relating to prior |
---|
7 | | - | authorization for health insurance; to provide for a legislative management study; to provide for |
---|
8 | | - | a legislative management report; and to provide an effective date. |
---|
| 1 | + | 25.1180.04000 |
---|
| 2 | + | Sixty-ninth |
---|
| 3 | + | Legislative Assembly |
---|
| 4 | + | of North Dakota |
---|
| 5 | + | Introduced by |
---|
| 6 | + | Senators Meyer, Barta, Bekkedahl, Cleary |
---|
| 7 | + | Representatives Nelson, Warrey |
---|
| 8 | + | A BILL for an Act to create and enact chapter 26.1-36.12 of the North Dakota Century Code, |
---|
| 9 | + | relating to prior authorization for health insurance; to provide for a legislative management |
---|
| 10 | + | study; to provide for a legislative management report; and to provide an effective date. |
---|
20 | | - | 3."Authorization" means a determination by a prior authorization review organization that a |
---|
21 | | - | health care service has been reviewed and, based on the information provided, satisfies the |
---|
22 | | - | prior authorization review organization's requirements for medical necessity and |
---|
23 | | - | appropriateness, and payment will be made for that health care service. |
---|
24 | | - | 4."Clinical criteria" means the written policies, written screening procedures, drug formularies or |
---|
25 | | - | lists of covered drugs, determination rules, determination abstracts, clinical protocols, practice |
---|
26 | | - | guidelines, medical protocols, and any other criteria or rationale used by the prior |
---|
27 | | - | authorization review organization to determine the necessity and appropriateness of health |
---|
28 | | - | care services. |
---|
| 22 | + | 3."Authorization" means a determination by a prior authorization review organization that |
---|
| 23 | + | a health care service has been reviewed and, based on the information provided, |
---|
| 24 | + | satisfies the prior authorization review organization's requirements for medical |
---|
| 25 | + | necessity and appropriateness, and payment will be made for that health care service. |
---|
| 26 | + | 4."Clinical criteria" means the written policies, written screening procedures, drug |
---|
| 27 | + | formularies or lists of covered drugs, determination rules, determination abstracts, |
---|
| 28 | + | clinical protocols, practice guidelines, medical protocols, and any other criteria or |
---|
| 29 | + | Page No. 1 25.1180.04000 |
---|
| 30 | + | ENGROSSED SENATE BILL NO. 2280 |
---|
| 31 | + | FIRST ENGROSSMENT |
---|
| 32 | + | with House Amendments |
---|
| 33 | + | 1 |
---|
| 34 | + | 2 |
---|
| 35 | + | 3 |
---|
| 36 | + | 4 |
---|
| 37 | + | 5 |
---|
| 38 | + | 6 |
---|
| 39 | + | 7 |
---|
| 40 | + | 8 |
---|
| 41 | + | 9 |
---|
| 42 | + | 10 |
---|
| 43 | + | 11 |
---|
| 44 | + | 12 |
---|
| 45 | + | 13 |
---|
| 46 | + | 14 |
---|
| 47 | + | 15 |
---|
| 48 | + | 16 |
---|
| 49 | + | 17 |
---|
| 50 | + | 18 |
---|
| 51 | + | 19 |
---|
| 52 | + | 20 |
---|
| 53 | + | 21 Sixty-ninth |
---|
| 54 | + | Legislative Assembly |
---|
| 55 | + | rationale used by the prior authorization review organization to determine the |
---|
| 56 | + | necessity and appropriateness of health care services. |
---|
31 | | - | 6."Emergency medical condition" means a medical condition that manifests itself by symptoms |
---|
32 | | - | of sufficient severity which may include pain and that a prudent layperson who possesses an |
---|
33 | | - | average knowledge of health and medicine could reasonably expect the absence of medical |
---|
34 | | - | attention to result in placing the individual's health in jeopardy, impairment of a bodily function, |
---|
35 | | - | or dysfunction of any body part. |
---|
36 | | - | 7."Enrollee" means an individual who has contracted for or who participates in coverage under a |
---|
37 | | - | policy for that individual or that individual's eligible dependents. |
---|
38 | | - | 8."Health care services" means health care procedures, treatments, or services provided by a |
---|
39 | | - | licensed facility or provided by a licensed physician or within the scope of practice for which a |
---|
40 | | - | health care professional is licensed. The term includes the provision of pharmaceutical |
---|
41 | | - | products or serv ices or durable medical equipment. S. B. NO. 2280 - PAGE 2 |
---|
42 | | - | 9."Medically necessary" as the term applies to health care services means health care services |
---|
43 | | - | a prudent physician would provide to a patient for the purpose of preventing, diagnosing, or |
---|
44 | | - | treating an illness, injury, disease, or its symptoms in a manner that is: |
---|
| 59 | + | 6."Emergency medical condition" means a medical condition that manifests itself by |
---|
| 60 | + | symptoms of sufficient severity which may include pain and that a prudent layperson |
---|
| 61 | + | who possesses an average knowledge of health and medicine could reasonably |
---|
| 62 | + | expect the absence of medical attention to result in placing the individual's health in |
---|
| 63 | + | jeopardy, impairment of a bodily function, or dysfunction of any body part. |
---|
| 64 | + | 7."Enrollee" means an individual who has contracted for or who participates in coverage |
---|
| 65 | + | under a policy for that individual or that individual's eligible dependents. |
---|
| 66 | + | 8."Health care services" means health care procedures, treatments, or services |
---|
| 67 | + | provided by a licensed facility or provided by a licensed physician or within the scope |
---|
| 68 | + | of practice for which a health care professional is licensed. The term includes the |
---|
| 69 | + | provision of pharmaceutical products or serv ices or durable medical equipment. |
---|
| 70 | + | 9."Medically necessary" as the term applies to health care services means health care |
---|
| 71 | + | services a prudent physician would provide to a patient for the purpose of preventing, |
---|
| 72 | + | diagnosing, or treating an illness, injury, disease, or its symptoms in a manner that is: |
---|
47 | | - | c.Not primarily for the economic benefit of the health plans and purchasers or for the |
---|
48 | | - | convenience of the patient, treating physician, or other health care provider. |
---|
49 | | - | 10."Medication-assisted treatment" means the use of medications, commonly in combination with |
---|
50 | | - | counseling and behavioral therapies, to provide a comprehensive approach to the treatment of |
---|
51 | | - | substance use disorders. United States food and drug administration-approved medications |
---|
52 | | - | used to treat opioid addiction include methadone and buprenorphine, alone or in combination |
---|
53 | | - | with naloxone and extended-release injectable naltrexone. Types of behavioral therapies |
---|
54 | | - | include individual therapy, group counseling, family behavior therapy, motivational incentives, |
---|
55 | | - | and other modalities. |
---|
56 | | - | 11."Policy" means a health benefit plan as defined in section 26.1 - 36.3 - 01. The te rm does not |
---|
57 | | - | include medical assistance or the public employees retirement system uniform group |
---|
58 | | - | insurance program plans under chapter 54 - 52.1. |
---|
59 | | - | 12."Prior authorization" means the review conducted before the delivery of a health care service, |
---|
60 | | - | including an outpatient health care service, to evaluate the necessity, appropriateness, and |
---|
61 | | - | efficacy of the use of health care services, procedures, and facilities, by a person other than |
---|
62 | | - | the attending health care professional, for the purpose of determining the medical necessity of |
---|
63 | | - | the health care services or admission. The term includes a review conducted after the |
---|
64 | | - | admission of the enrollee and in situations in which the enrollee is unconscious or otherwise |
---|
65 | | - | unable to provide advance notification. The term does not include a referral or participation in |
---|
66 | | - | a referral process by a participating provider unless the provider is acting as a prior |
---|
67 | | - | authorization review organization. |
---|
68 | | - | 13."Prior authorization review organization" means a person that performs prior authorization for: |
---|
| 75 | + | c.Not primarily for the economic benefit of the health plans and purchasers or for |
---|
| 76 | + | the convenience of the patient, treating physician, or other health care provider. |
---|
| 77 | + | 10."Medication assisted treatment" means the use of medications, commonly in |
---|
| 78 | + | combination with counseling and behavioral therapies, to provide a comprehensive |
---|
| 79 | + | approach to the treatment of substance use disorders. United States food and drug |
---|
| 80 | + | administration-approved medications used to treat opioid addiction include methadone |
---|
| 81 | + | and buprenorphine, alone or in combination with naloxone and extended-release |
---|
| 82 | + | injectable naltrexone. Types of behavioral therapies include individual therapy, group |
---|
| 83 | + | counseling, family behavior therapy, motivational incentives, and other modalities. |
---|
| 84 | + | Page No. 2 25.1180.04000 |
---|
| 85 | + | 1 |
---|
| 86 | + | 2 |
---|
| 87 | + | 3 |
---|
| 88 | + | 4 |
---|
| 89 | + | 5 |
---|
| 90 | + | 6 |
---|
| 91 | + | 7 |
---|
| 92 | + | 8 |
---|
| 93 | + | 9 |
---|
| 94 | + | 10 |
---|
| 95 | + | 11 |
---|
| 96 | + | 12 |
---|
| 97 | + | 13 |
---|
| 98 | + | 14 |
---|
| 99 | + | 15 |
---|
| 100 | + | 16 |
---|
| 101 | + | 17 |
---|
| 102 | + | 18 |
---|
| 103 | + | 19 |
---|
| 104 | + | 20 |
---|
| 105 | + | 21 |
---|
| 106 | + | 22 |
---|
| 107 | + | 23 |
---|
| 108 | + | 24 |
---|
| 109 | + | 25 |
---|
| 110 | + | 26 |
---|
| 111 | + | 27 |
---|
| 112 | + | 28 |
---|
| 113 | + | 29 Sixty-ninth |
---|
| 114 | + | Legislative Assembly |
---|
| 115 | + | 11."Policy" means a health benefit plan as defined in section 26.1 - 36.3 - 01. The te rm does |
---|
| 116 | + | not include medical assistance or the public employees retirement system uniform |
---|
| 117 | + | group insurance program plans under chapter 54 - 52.1. |
---|
| 118 | + | 12."Prior authorization" means the review conducted before the delivery of a health care |
---|
| 119 | + | service, including an outpatient health care service, to evaluate the necessity, |
---|
| 120 | + | appropriateness, and efficacy of the use of health care services, procedures, and |
---|
| 121 | + | facilities, by a person other than the attending health care professional, for the |
---|
| 122 | + | purpose of determining the medical necessity of the health care services or admission. |
---|
| 123 | + | The term includes a review conducted after the admission of the enrollee and in |
---|
| 124 | + | situations in which the enrollee is unconscious or otherwise unable to provide advance |
---|
| 125 | + | notification. The term does not include a referral or participation in a referral process |
---|
| 126 | + | by a participating provider unless the provider is acting as a prior authorization review |
---|
| 127 | + | organization. |
---|
| 128 | + | 13."Prior authorization review organization" means a person that performs prior |
---|
| 129 | + | authorization for: |
---|
72 | | - | d.Any other person that provides, offers to provide, or administers hospital, outpatient, |
---|
73 | | - | medical, prescription drug, or other health benefits to an individual treated by a health |
---|
74 | | - | care professional in the state under a policy. |
---|
75 | | - | 14."Urgent health care service" means a health care service for which, in the opinion of a health |
---|
76 | | - | care professional with knowledge of the enrollee's medical condition, the application of the |
---|
77 | | - | time periods for making a nonexpedited prior authorization might: |
---|
| 133 | + | d.Any other person that provides, offers to provide, or administers hospital, |
---|
| 134 | + | outpatient, medical, prescription drug, or other health benefits to an individual |
---|
| 135 | + | treated by a health care professional in the state under a policy. |
---|
| 136 | + | 14."Urgent health care service" means a health care service for which, in the opinion of a |
---|
| 137 | + | health care professional with knowledge of the enrollee's medical condition, the |
---|
| 138 | + | application of the time periods for making a non-expedited prior authorization might: |
---|
83 | | - | 1.A prior authorization review organization shall make any prior authorization requirements and |
---|
84 | | - | restrictions readily accessible on the organization's website to enrollees, health care S. B. NO. 2280 - PAGE 3 |
---|
85 | | - | professionals, and the general public. Requirements include the written clinical criteria and be |
---|
86 | | - | described in detail using plain and ordinary language comprehensible by a layperson. |
---|
87 | | - | 2.If a prior authorization review organization intends to implement a new prior authorization |
---|
88 | | - | requirement or restriction, or amend an existing requirement or restriction, the prior |
---|
89 | | - | authorization review organization shall: |
---|
| 144 | + | 1.A prior authorization review organization shall make any prior authorization |
---|
| 145 | + | requirements and restrictions readily accessible on the organization's website to |
---|
| 146 | + | Page No. 3 25.1180.04000 |
---|
| 147 | + | 1 |
---|
| 148 | + | 2 |
---|
| 149 | + | 3 |
---|
| 150 | + | 4 |
---|
| 151 | + | 5 |
---|
| 152 | + | 6 |
---|
| 153 | + | 7 |
---|
| 154 | + | 8 |
---|
| 155 | + | 9 |
---|
| 156 | + | 10 |
---|
| 157 | + | 11 |
---|
| 158 | + | 12 |
---|
| 159 | + | 13 |
---|
| 160 | + | 14 |
---|
| 161 | + | 15 |
---|
| 162 | + | 16 |
---|
| 163 | + | 17 |
---|
| 164 | + | 18 |
---|
| 165 | + | 19 |
---|
| 166 | + | 20 |
---|
| 167 | + | 21 |
---|
| 168 | + | 22 |
---|
| 169 | + | 23 |
---|
| 170 | + | 24 |
---|
| 171 | + | 25 |
---|
| 172 | + | 26 |
---|
| 173 | + | 27 |
---|
| 174 | + | 28 |
---|
| 175 | + | 29 |
---|
| 176 | + | 30 |
---|
| 177 | + | 31 Sixty-ninth |
---|
| 178 | + | Legislative Assembly |
---|
| 179 | + | enrollees, health care professionals, and the general public. Requirements include the |
---|
| 180 | + | written clinical criteria and be described in detail using plain and ordinary language |
---|
| 181 | + | comprehensible by a layperson. |
---|
| 182 | + | 2.If a prior authorization review organization intends to implement a new prior |
---|
| 183 | + | authorization requirement or restriction, or amend an existing requirement or |
---|
| 184 | + | restriction, the prior authorization review organization shall: |
---|
108 | | - | b.Must be in active practice in the same or similar specialty as the physician who typically |
---|
109 | | - | manages the medical condition or disease for at least five consecutive years. |
---|
110 | | - | c.Must be knowledgeable of, and have experience providing, the health care services |
---|
111 | | - | under appeal. |
---|
112 | | - | d.May not receive any financial incentive based on the number of adverse determinations |
---|
113 | | - | made. This subdivision does not apply to financial incentives established between health |
---|
114 | | - | plan companies and health care providers. |
---|
| 203 | + | b.Must be in active practice in the same or similar specialty as the physician who |
---|
| 204 | + | typically manages the medical condition or disease for at least five consecutive |
---|
| 205 | + | years . |
---|
| 206 | + | c.Must be knowledgeable of, and have experience providing, the health care |
---|
| 207 | + | services under appeal . |
---|
| 208 | + | Page No. 4 25.1180.04000 |
---|
| 209 | + | 1 |
---|
| 210 | + | 2 |
---|
| 211 | + | 3 |
---|
| 212 | + | 4 |
---|
| 213 | + | 5 |
---|
| 214 | + | 6 |
---|
| 215 | + | 7 |
---|
| 216 | + | 8 |
---|
| 217 | + | 9 |
---|
| 218 | + | 10 |
---|
| 219 | + | 11 |
---|
| 220 | + | 12 |
---|
| 221 | + | 13 |
---|
| 222 | + | 14 |
---|
| 223 | + | 15 |
---|
| 224 | + | 16 |
---|
| 225 | + | 17 |
---|
| 226 | + | 18 |
---|
| 227 | + | 19 |
---|
| 228 | + | 20 |
---|
| 229 | + | 21 |
---|
| 230 | + | 22 |
---|
| 231 | + | 23 |
---|
| 232 | + | 24 |
---|
| 233 | + | 25 |
---|
| 234 | + | 26 |
---|
| 235 | + | 27 |
---|
| 236 | + | 28 |
---|
| 237 | + | 29 Sixty-ninth |
---|
| 238 | + | Legislative Assembly |
---|
| 239 | + | d.May not receive any financial incentive based on the number of adverse |
---|
| 240 | + | determinations made. This subdivision does not apply to financial incentives |
---|
| 241 | + | established between health plan companies and health care providers. |
---|
117 | | - | including a review of all pertinent medical records provided to the prior authorization |
---|
118 | | - | review organization by the enrollee's health care provider, any relevant records provided |
---|
119 | | - | to the prior authorization review organization by a health care facility, and any medical |
---|
120 | | - | literature provided to the prior authorization review organization by the health care |
---|
121 | | - | provider. |
---|
122 | | - | 2.A review of an adverse determination involving a prescription drug must be conducted by a |
---|
123 | | - | licensed pharmacist or physician who is competent to evaluate the specific clinical issues |
---|
124 | | - | presented in the review. |
---|
125 | | - | 3.This section does not apply to reviews conducted under sections 26.1 - 36 - 44 and 26.1 - 36 - 46. S. B. NO. 2280 - PAGE 4 |
---|
| 244 | + | including a review of all pertinent medical records provided to the prior |
---|
| 245 | + | authorization review organization by the enrollee's health care provider, any |
---|
| 246 | + | relevant records provided to the prior authorization review organization by a |
---|
| 247 | + | health care facility, and any medical literature provided to the prior authorization |
---|
| 248 | + | review organization by the health care provider. |
---|
| 249 | + | 2.A review of an adverse determination involving a prescription drug must be conducted |
---|
| 250 | + | by a licensed pharmacist or physician who is competent to evaluate the specific |
---|
| 251 | + | clinical issues presented in the review. |
---|
| 252 | + | 3.This section does not apply to reviews conducted under sections 26.1 - 36 - 44 and |
---|
| 253 | + | 26.1 - 36 - 46. |
---|
127 | | - | 1.If a prior authorization review organization requires prior authorization of a health care service, |
---|
128 | | - | the prior authorization review organization shall make a prior authorization or adverse |
---|
129 | | - | determination and notify the enrollee and the enrollee's health care provider of the decision |
---|
130 | | - | within seven calendar days of obtaining all necessary information to make the decision. For |
---|
131 | | - | purposes of this section, "necessary information" includes the results of any face-to-face |
---|
132 | | - | clinical evaluation or second opinion that may be required. |
---|
133 | | - | 2.A prior authorization review organization shall have written procedures to address the failure |
---|
134 | | - | of a health care provider or enrollee to provide the necessary information to make a |
---|
135 | | - | determination on the request. If the health care provider or enrollee fails to provide the |
---|
136 | | - | necessary information to the prior authorization review organization within fourteen calendar |
---|
137 | | - | days of a written request for all necessary information, the prior authorization review |
---|
138 | | - | organization may make an adverse determination. |
---|
139 | | - | 3.A prior authorization review organization shall allow an enrollee and the enrollee's health care |
---|
140 | | - | provider at least fourteen business days to request an updated prior authorization following an |
---|
141 | | - | unforeseen change in the circumstances or care needs for the enrollee following a nonurgent |
---|
142 | | - | circumstance or provision of health care services for the enrollee. |
---|
| 255 | + | 1.If a prior authorization review organization requires prior authorization of a health care |
---|
| 256 | + | service, the prior authorization review organization shall make a prior authorization or |
---|
| 257 | + | adverse determination and notify the enrollee and the enrollee's health care provider |
---|
| 258 | + | of the decision within seven calendar days of obtaining all necessary information to |
---|
| 259 | + | make the decision. For purposes of this section, "necessary information" includes the |
---|
| 260 | + | results of any face-to-face clinical evaluation or second opinion that may be required. |
---|
| 261 | + | 2.A prior authorization review organization shall have written procedures to address the |
---|
| 262 | + | failure of a health care provider or enrollee to provide the necessary information to |
---|
| 263 | + | make a determination on the request. If the health care provider or enrollee fails to |
---|
| 264 | + | provide the necessary information to the prior authorization review organization within |
---|
| 265 | + | fourteen calendar days of a written request for all necessary information, the prior |
---|
| 266 | + | authorization review organization may make an adverse determination. |
---|
| 267 | + | 3.A prior authorization review organization shall allow an enrollee and the enrollee's |
---|
| 268 | + | health care provider at least fourteen business days to request an updated prior |
---|
| 269 | + | authorization following an unforeseen change in the circumstances or care needs for |
---|
| 270 | + | Page No. 5 25.1180.04000 |
---|
| 271 | + | 1 |
---|
| 272 | + | 2 |
---|
| 273 | + | 3 |
---|
| 274 | + | 4 |
---|
| 275 | + | 5 |
---|
| 276 | + | 6 |
---|
| 277 | + | 7 |
---|
| 278 | + | 8 |
---|
| 279 | + | 9 |
---|
| 280 | + | 10 |
---|
| 281 | + | 11 |
---|
| 282 | + | 12 |
---|
| 283 | + | 13 |
---|
| 284 | + | 14 |
---|
| 285 | + | 15 |
---|
| 286 | + | 16 |
---|
| 287 | + | 17 |
---|
| 288 | + | 18 |
---|
| 289 | + | 19 |
---|
| 290 | + | 20 |
---|
| 291 | + | 21 |
---|
| 292 | + | 22 |
---|
| 293 | + | 23 |
---|
| 294 | + | 24 |
---|
| 295 | + | 25 |
---|
| 296 | + | 26 |
---|
| 297 | + | 27 |
---|
| 298 | + | 28 |
---|
| 299 | + | 29 |
---|
| 300 | + | 30 |
---|
| 301 | + | 31 Sixty-ninth |
---|
| 302 | + | Legislative Assembly |
---|
| 303 | + | the enrollee following a nonurgent circumstance or provision of health care services |
---|
| 304 | + | for the enrollee . |
---|
149 | | - | 1.A prior authorization review organization may not require prior authorization for prehospital |
---|
150 | | - | transportation or for the provision of emergency health care services for an emergency |
---|
151 | | - | medical condition. |
---|
152 | | - | 2.A prior authorization review organization shall allow an enrollee and the enrollee's health care |
---|
153 | | - | provider a minimum of two business days following an emergency admission or provision of |
---|
154 | | - | emergency health care services for an emergency medical condition for the enrollee or health |
---|
155 | | - | care provider to notify the prior authorization review organization of the admission or provision |
---|
156 | | - | of health care services. |
---|
| 312 | + | 1.A prior authorization review organization may not require prior authorization for |
---|
| 313 | + | prehospital transportation or for the provision of emergency health care services for an |
---|
| 314 | + | emergency medical condition. |
---|
| 315 | + | 2.A prior authorization review organization shall allow an enrollee and the enrollee's |
---|
| 316 | + | health care provider a minimum of two business days following an emergency |
---|
| 317 | + | admission or provision of emergency health care services for an emergency medical |
---|
| 318 | + | condition for the enrollee or health care provider to notify the prior authorization review |
---|
| 319 | + | organization of the admission or provision of health care services. |
---|
161 | | - | postevaluation or poststabilization services, a prior authorization review organization shall |
---|
162 | | - | make an authorization determination within two business days of receiving a request. If the |
---|
163 | | - | authorization determination is not made within two business days, the services must be |
---|
164 | | - | deemed approved. |
---|
165 | | - | 26.1 - 36.12 - 08. No prior authorization for medication-assisted treatment. |
---|
166 | | - | A prior authorization review organization may not require prior authorization for the provision of |
---|
167 | | - | medication-assisted treatment for the treatment of opioid use disorder. S. B. NO. 2280 - PAGE 5 |
---|
| 324 | + | postevaluation or poststabilization services, a prior authorization review organization |
---|
| 325 | + | shall make an authorization determination within two business days of receiving a |
---|
| 326 | + | request. If the authorization determination is not made within two business days, the |
---|
| 327 | + | services must be deemed approved. |
---|
| 328 | + | 26.1 - 36.12 - 08. No prior authorization for medication assisted treatment. |
---|
| 329 | + | A prior authorization review organization may not require prior authorization for the |
---|
| 330 | + | provision of medication assisted treatment for the treatment of opioid use disorder. |
---|
180 | | - | 1.On receipt of information documenting a prior authorization from the enrollee or from the |
---|
181 | | - | enrollee's health care provider, a prior authorization review organization shall honor a prior |
---|
182 | | - | authorization granted to an enrollee from a previous prior authorization review organization for |
---|
183 | | - | at least the initial sixty days of an enrollee's coverage under a new policy, provided the health |
---|
184 | | - | care service for which the enrollee has received prior authorization is covered under the new |
---|
185 | | - | policy. To obtain coverage, the enrollee or health care provider shall submit documentation of |
---|
186 | | - | the previous prior authorization in accordance with the procedures in the enrollee's new policy. |
---|
187 | | - | 2.During the time period described in subsection 1, a prior authorization review organization |
---|
188 | | - | may perform its review to grant a prior authorization. |
---|
189 | | - | 3.If there is a change in coverage of, or approval criteria for, a previously authorized health care |
---|
190 | | - | service, the change in coverage or approval criteria does not affect an enrollee who received |
---|
191 | | - | prior authorization before the effective date of the change for the remainder of the enrollee's |
---|
192 | | - | plan year. This subsection does not apply if a prior authorization review organization changes |
---|
| 377 | + | 1.On receipt of information documenting a prior authorization from the enrollee or from |
---|
| 378 | + | the enrollee's health care provider, a prior authorization review organization shall |
---|
| 379 | + | honor a prior authorization granted to an enrollee from a previous prior authorization |
---|
| 380 | + | review organization for at least the initial sixty days of an enrollee's coverage under a |
---|
| 381 | + | new policy, provided the health care service for which the enrollee has received prior |
---|
| 382 | + | authorization is covered under the new policy. To obtain coverage, the enrollee or |
---|
| 383 | + | health care provider shall submit documentation of the previous prior authorization in |
---|
| 384 | + | accordance with the procedures in the enrollee's new policy. |
---|
| 385 | + | 2.During the time period described in subsection 1, a prior authorization review |
---|
| 386 | + | organization may perform its review to grant a prior authorization. |
---|
| 387 | + | 3.If there is a change in coverage of, or approval criteria for, a previously authorized |
---|
| 388 | + | health care service, the change in coverage or approval criteria does not affect an |
---|
| 389 | + | enrollee who received prior authorization before the effective date of the change for |
---|
| 390 | + | the remainder of the enrollee's plan year. This subsection does not apply if a prior |
---|
| 391 | + | authorization review organization changes coverage terms for a drug or device that |
---|
| 392 | + | has been: |
---|
| 393 | + | a.Deemed unsafe by the United States food and drug administration; or |
---|
| 394 | + | b.Withdrawn by the United States food and drug administration or product |
---|
| 395 | + | manufacturer. |
---|
| 396 | + | 4.A prior authorization review organization shall continue to honor a prior authorization |
---|
| 397 | + | the organization has granted to an enrollee if the enrollee changes products under the |
---|
| 398 | + | Page No. 7 25.1180.04000 |
---|
| 399 | + | 1 |
---|
| 400 | + | 2 |
---|
| 401 | + | 3 |
---|
| 402 | + | 4 |
---|
| 403 | + | 5 |
---|
| 404 | + | 6 |
---|
| 405 | + | 7 |
---|
| 406 | + | 8 |
---|
| 407 | + | 9 |
---|
| 408 | + | 10 |
---|
| 409 | + | 11 |
---|
| 410 | + | 12 |
---|
| 411 | + | 13 |
---|
| 412 | + | 14 |
---|
| 413 | + | 15 |
---|
| 414 | + | 16 |
---|
| 415 | + | 17 |
---|
| 416 | + | 18 |
---|
| 417 | + | 19 |
---|
| 418 | + | 20 |
---|
| 419 | + | 21 |
---|
| 420 | + | 22 |
---|
| 421 | + | 23 |
---|
| 422 | + | 24 |
---|
| 423 | + | 25 |
---|
| 424 | + | 26 |
---|
| 425 | + | 27 |
---|
| 426 | + | 28 |
---|
| 427 | + | 29 |
---|
| 428 | + | 30 |
---|
| 429 | + | 31 Sixty-ninth |
---|
| 430 | + | Legislative Assembly |
---|
| 431 | + | same health insurance company provided the health care service for which the |
---|
| 432 | + | enrollee has received prior authorization is covered under the new policy. |
---|
| 433 | + | 26.1 - 36.12 - 13. Failure to comply - Services deemed authorized. |
---|
| 434 | + | If a prior authorization review organization fails to comply with the deadlines and other |
---|
| 435 | + | requirements in this chapter, any health care services subject to review automatically are |
---|
| 436 | + | deemed authorized by the prior authorization review organization. |
---|
| 437 | + | 26.1 - 36.12 - 14. Procedures for appeals of adverse determinations. |
---|
| 438 | + | 1.A prior authorization review organization shall have written procedures for appeals of |
---|
| 439 | + | adverse determinations. The right to appeal must be available to the enrollee and the |
---|
| 440 | + | attending health care professional. |
---|
| 441 | + | 2.The enrollee may review the information relied on in the course of the appeal, present |
---|
| 442 | + | evidence and testimony as part of the appeals process, and receive continued |
---|
| 443 | + | coverage pending the outcome of the appeals process. |
---|
| 444 | + | 26.1 - 36.12 - 15. Effect of change in prior authorization clinical criteria. |
---|
| 445 | + | 1.If, during a plan year, a prior authorization review organization changes coverage |
---|
| 446 | + | terms for a health care service or the clinical criteria used to conduct prior |
---|
| 447 | + | authorizations for a health care service, the change in coverage terms or in clinical |
---|
| 448 | + | criteria does not apply until the next plan year for any enrollee who received prior |
---|
| 449 | + | authorization for a health care service using the coverage terms or clinical criteria in |
---|
| 450 | + | effect before the effective date of the change. |
---|
| 451 | + | 2.This section does not apply if a prior authorization review organization changes |
---|
195 | | - | b.Withdrawn by the United States food and drug administration or product manufacturer. |
---|
196 | | - | 4.A prior authorization review organization shall continue to honor a prior authorization the |
---|
197 | | - | organization has granted to an enrollee if the enrollee changes products under the same |
---|
198 | | - | health insurance company provided the health care service for which the enrollee has |
---|
199 | | - | received prior authorization is covered under the new policy. |
---|
200 | | - | 26.1 - 36.12 - 13. Failure to comply - Services deemed authorized. |
---|
201 | | - | If a prior authorization review organization fails to comply with the deadlines and other requirements |
---|
202 | | - | in this chapter, any health care services subject to review automatically are deemed authorized by the |
---|
203 | | - | prior authorization review organization. |
---|
204 | | - | 26.1 - 36.12 - 14. Procedures for appeals of adverse determinations. |
---|
205 | | - | 1.A prior authorization review organization shall have written procedures for appeals of adverse |
---|
206 | | - | determinations. The right to appeal must be available to the enrollee and the attending health |
---|
207 | | - | care professional. S. B. NO. 2280 - PAGE 6 |
---|
208 | | - | 2.The enrollee may review the information relied on in the course of the appeal, present |
---|
209 | | - | evidence and testimony as part of the appeals process, and receive continued coverage |
---|
210 | | - | pending the outcome of the appeals process. |
---|
211 | | - | 26.1 - 36.12 - 15. Effect of change in prior authorization clinical criteria. |
---|
212 | | - | 1.If, during a plan year, a prior authorization review organization changes coverage terms for a |
---|
213 | | - | health care service or the clinical criteria used to conduct prior authorizations for a health care |
---|
214 | | - | service, the change in coverage terms or in clinical criteria does not apply until the next plan |
---|
215 | | - | year for any enrollee who received prior authorization for a health care service using the |
---|
216 | | - | coverage terms or clinical criteria in effect before the effective date of the change. |
---|
217 | | - | 2.This section does not apply if a prior authorization review organization changes coverage |
---|
218 | | - | terms for a drug or device that has been: |
---|
219 | | - | a.Deemed unsafe by the United States food and drug administration; or |
---|
220 | | - | b.Withdrawn by the United States food and drug administration or product manufacturer. |
---|
| 454 | + | b.Withdrawn by the United States food and drug administration or product |
---|
| 455 | + | manufacturer. |
---|
251 | | - | authorization requirements imposed by the public employees retirement system uniform group |
---|
252 | | - | insurance plans under chapter 54-52.1 and the impact on patient care and health care costs. |
---|
253 | | - | 2.The study must include input from stakeholders, including patients, providers, and commercial |
---|
254 | | - | insurance plans. |
---|
255 | | - | 3.The study must require insurance plans to submit to the insurance commissioner by July 1, |
---|
256 | | - | 2025, for the immediately preceding calendar year for each commercial product: |
---|
257 | | - | a.The number of prior authorization requests for which an authorization was issued; |
---|
258 | | - | b.The number of prior authorization requests for which an adverse determination was |
---|
259 | | - | issued, sorted by health care service, whether the adverse determination was appealed, |
---|
260 | | - | or whether the adverse determination was upheld or reversed on appeal; |
---|
| 521 | + | authorization requirements imposed by the public employees retirement system |
---|
| 522 | + | uniform group insurance plans under chapter 54-52.1 and the impact on patient care |
---|
| 523 | + | and health care costs. |
---|
| 524 | + | 2.The study must include input from stakeholders, including patients, providers, and |
---|
| 525 | + | commercial insurance plans. |
---|
| 526 | + | Page No. 9 25.1180.04000 |
---|
| 527 | + | 1 |
---|
| 528 | + | 2 |
---|
| 529 | + | 3 |
---|
| 530 | + | 4 |
---|
| 531 | + | 5 |
---|
| 532 | + | 6 |
---|
| 533 | + | 7 |
---|
| 534 | + | 8 |
---|
| 535 | + | 9 |
---|
| 536 | + | 10 |
---|
| 537 | + | 11 |
---|
| 538 | + | 12 |
---|
| 539 | + | 13 |
---|
| 540 | + | 14 |
---|
| 541 | + | 15 |
---|
| 542 | + | 16 |
---|
| 543 | + | 17 |
---|
| 544 | + | 18 |
---|
| 545 | + | 19 |
---|
| 546 | + | 20 |
---|
| 547 | + | 21 |
---|
| 548 | + | 22 |
---|
| 549 | + | 23 |
---|
| 550 | + | 24 |
---|
| 551 | + | 25 |
---|
| 552 | + | 26 |
---|
| 553 | + | 27 |
---|
| 554 | + | 28 |
---|
| 555 | + | 29 |
---|
| 556 | + | 30 |
---|
| 557 | + | 31 Sixty-ninth |
---|
| 558 | + | Legislative Assembly |
---|
| 559 | + | 3.The study must require insurance plans to submit to the insurance commissioner by |
---|
| 560 | + | July 1, 2025, for the immediately preceding calendar year for each commercial |
---|
| 561 | + | product: |
---|
| 562 | + | a.The number of prior authorization requests for which an authorization was |
---|
| 563 | + | issued; |
---|
| 564 | + | b.The number of prior authorization requests for which an adverse determination |
---|
| 565 | + | was issued, sorted by health care service, whether the adverse determination |
---|
| 566 | + | was appealed, or whether the adverse determination was upheld or reversed on |
---|
| 567 | + | appeal; |
---|
268 | | - | 5.The legislative management shall report its findings and recommendations, together with any |
---|
269 | | - | legislation required to implement the recommendations, to the seventieth legislative assembly. |
---|
270 | | - | SECTION 3. LEGISLATIVE MANAGEMENT STUDY - PRIOR AUTHORIZATION ELECTRONIC |
---|
271 | | - | HEALTH RECORDS FOR NONURGENT AND EMERGENCY HEALTH CARE SERVICES. During the |
---|
272 | | - | 2025-26 interim, the legislative management shall consider studying the ability for health care systems |
---|
273 | | - | and providers to submit prior authorization reviews for nonurgent and emergency health care services |
---|
274 | | - | by secure electronic means. The study must analyze alternatives to facsimile or mail for transmitting |
---|
275 | | - | prior authorization requests and the supporting medical records. The study must include input from |
---|
276 | | - | stakeholders, including patients, providers, and commercial insurance plans. The legislative |
---|
277 | | - | management shall report its findings and recommendations, together with any legislation required to |
---|
278 | | - | implement the recommendations, to the seventieth legislative assembly. |
---|
279 | | - | SECTION 4. EFFECTIVE DATE. This Act becomes effective on January 1, 2026. S. B. NO. 2280 - PAGE 8 |
---|
280 | | - | ____________________________ ____________________________ |
---|
281 | | - | President of the Senate Speaker of the House |
---|
282 | | - | ____________________________ ____________________________ |
---|
283 | | - | Secretary of the Senate Chief Clerk of the House |
---|
284 | | - | This certifies that the within bill originated in the Senate of the Sixty-ninth Legislative Assembly of North |
---|
285 | | - | Dakota and is known on the records of that body as Senate Bill No. 2280. |
---|
286 | | - | Senate Vote:Yeas 43 Nays 3 Absent 1 |
---|
287 | | - | House Vote: Yeas 93 Nays 0 Absent 1 |
---|
288 | | - | ____________________________ |
---|
289 | | - | Secretary of the Senate |
---|
290 | | - | Received by the Governor at ________M. on _____________________________________, 2025. |
---|
291 | | - | Approved at ________M. on __________________________________________________, 2025. |
---|
292 | | - | ____________________________ |
---|
293 | | - | Governor |
---|
294 | | - | Filed in this office this ___________day of _______________________________________, 2025, |
---|
295 | | - | at ________ o’clock ________M. |
---|
296 | | - | ____________________________ |
---|
297 | | - | Secretary of State |
---|
| 575 | + | 5.The legislative management shall report its findings and recommendations, together |
---|
| 576 | + | with any legislation required to implement the recommendations, to the seventieth |
---|
| 577 | + | legislative assembly. |
---|
| 578 | + | SECTION 3. LEGISLATIVE MANAGEMENT STUDY - PRIOR AUTHORIZATION |
---|
| 579 | + | ELECTRONIC HEALTH RECORDS FOR NONURGENT AND EMERGENCY HEALTH CARE |
---|
| 580 | + | SERVICES. During the 2025-26 interim, the legislative management shall consider studying the |
---|
| 581 | + | ability for health care systems and providers to submit prior authorization reviews for nonurgent |
---|
| 582 | + | and emergency health care services by secure electronic means. The study must analyze |
---|
| 583 | + | alternatives to facsimile or mail for transmitting prior authorization requests and the supporting |
---|
| 584 | + | medical records. The study must include input from stakeholders, including patients, providers, |
---|
| 585 | + | and commercial insurance plans. The legislative management shall report its findings and |
---|
| 586 | + | recommendations, together with any legislation required to implement the recommendations, to |
---|
| 587 | + | the seventieth legislative assembly. |
---|
| 588 | + | SECTION 4. EFFECTIVE DATE. This Act becomes effective on January 1, 2026. |
---|
| 589 | + | Page No. 10 25.1180.04000 |
---|
| 590 | + | 1 |
---|
| 591 | + | 2 |
---|
| 592 | + | 3 |
---|
| 593 | + | 4 |
---|
| 594 | + | 5 |
---|
| 595 | + | 6 |
---|
| 596 | + | 7 |
---|
| 597 | + | 8 |
---|
| 598 | + | 9 |
---|
| 599 | + | 10 |
---|
| 600 | + | 11 |
---|
| 601 | + | 12 |
---|
| 602 | + | 13 |
---|
| 603 | + | 14 |
---|
| 604 | + | 15 |
---|
| 605 | + | 16 |
---|
| 606 | + | 17 |
---|
| 607 | + | 18 |
---|
| 608 | + | 19 |
---|
| 609 | + | 20 |
---|
| 610 | + | 21 |
---|
| 611 | + | 22 |
---|
| 612 | + | 23 |
---|
| 613 | + | 24 |
---|
| 614 | + | 25 |
---|
| 615 | + | 26 |
---|
| 616 | + | 27 |
---|
| 617 | + | 28 |
---|
| 618 | + | 29 |
---|
| 619 | + | 30 |
---|